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Tetanus in an intensive care unit of a Turkish hospital: Patient
analysis of a 6-year period
Behice KURTARAN1, Emre KARAKOÇ2, Aslıhan CANDEVİR1, Süheyla KÖMÜR1, Ayşe S. İNAL1,
Filiz KİBAR3, Yeşim TAŞOVA1, Neşe SALTOĞLU1, Hasan Salih Zeki AKSU1

Aim: To retrospectively evaluate the clinical features of patients admitted to the medical intensive care unit (ICU) of our
hospital between January 2001 and May 2007 due to tetanus.
Materials and methods: Patient vaccination history, incubation period, nosocomial infections, noninfectious conditions,
mortality, and length of stay in the ICU and hospital were documented.
Results: Fifteen tetanus patients were admitted during the 6-year period. Mean age of the patients (9 male, 6 female) was
60 ± 13 years. Median length of stay was 42 days (range: 30-77 days) for survivors and 7 days (range: 1-59 days) for nonsurvivors. Mortality was consequent to severe tetanus in 5 patients, sepsis in 2 patients, and myocardial infarction in 1
patient. One patient died due to complications of acute renal failure, and another died due to acute pancreatitis and renal
failure. The mortality rate was 66%. Seven patients had nosocomial infections (16 episodes). Ventilator-associated
pneumonia was the most common infection, followed by primary bacteremia and urinary tract infection.
Conclusion: Although it is preventable with vaccination, tetanus remains a problem, especially for the elderly population.
Despite intensive support, the mortality rate in our tetanus patients was high.
Key words: Tetanus, intensive care unit, nosocomial infection, mortality

Bir Türk hastanesi yoğun bakım ünitesi’nde tetanoz: 6 yıllık hasta analizi
Amaç: Bu çalışmada, Ocak 2001 ve Mayıs 2007 arasında hastanemiz dahiliye yoğun bakım ünitesinde (YBÜ) tetanoz
tanısı ile izlenen hastaların klinik seyri retrospektif olarak değerlendirilmiştir.
Yöntem ve gereç: Hastaların aşılanma öyküsü, inkübasyon süreleri, nozokomiyal infeksiyonları, infeksiyon dışı
durumları, mortalite ve hastane ve YBÜ’nde yatış süreleri kaydedilmiştir.
Bulgular: Onbeş tetanoz hastası bu dönem içinde izlenmiştir. Ortalama yaş 60 ± 13 yıl olarak kaydedilmiştir. Bu
hastaların dokuzu erkektir. Ortanca yatış süresi yaşayanlarda 42 (30-77) gün ve kaybedilenlerde 7 (1-59) gün olarak
saptanmıştır. Ölümlerin beşi ağır tetanoz tablosu, ikisi sepsis ve biri miyokard enfarktüsü nedeniyle olmuştur. Bir hasta
akut böbrek yetmezliğine sekonder gelişen komplikasyon nedeni ile, bir diğeri ise akut pankreatit ve akut böbrek
yetmezliği nedeniyle kaybedilmiştir. Mortalite oranı % 66’dır. Yedi hastada nozokomiyal infeksiyon gelişmiştir (16 atak).
Ventilator ilişkili pnömoni en sık görülen infeksiyon olup, bunu primer bakteremi ve üriner sistem infeksiyonu izlemiştir.
Sonuç: Aşı ile önlenebilir olmasına karşın tetanoz, özellikle de yaşlı popülasyonda önemini korumaya devam etmektedir.
Mortalite yoğun desteğe karşın hala yüksektir.
Anahtar sözcükler: Tetanoz, yoğun bakım ünitesi, nozokomiyal infeksiyon, mortalite
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Introduction
Tetanus is an important infectious disease with a
high mortality rate due to the toxins’ action. It can be
prevented with appropriate vaccination programs.
Almost all tetanus patients are hospitalized in
intensive care units (ICUs) due to the risks of
mortality and morbidity, and are exposed to invasive
interventions and possible nosocomial infections. The
incubation period of the disease varies from 1 to 50
days (mean: 3-13 days) and it has been reported that
the proximity of the wound to the central nervous
system does not affect this period. Fever is unexpected
during the course of tetanus, except in cases with
complications, such as pneumonia and wound
infection, and during the terminal stage of the disease.
Typically, seizures with tonic, painful muscle spasms
occur in tetanus and patients may suffer from
seizures, even with the slightest stimulus. Death is
mostly due to asphyxia; however, secondary infections
may also contribute to mortality. The mortality rate
varies between 5% and 35%; in neonates this rate may
rise to about 60%.
Patients with tetanus should be vaccinated, as
tetanus does not confer immunity. If a patient is not
vaccinated or does not know his/her immunization
status, vaccination should be performed, together
with the administration of tetanus-immune globulin
(TIG: 250-500 U). The aim of the present study was to
determine the prevalence of tetanus in patients that
were followed up in our hospital, the prognostic
determinants of the disease, interventions undertaken
during their follow-up in the ICU, acquired
nosocomial infections, noninfectious complications,
and the mortality rate (1,2,6).
Materials and methods
Patient population and analysis
The study included 15 tetanus patients that were
follow-up in our hospital’s ICU between January 2001
and May 2007. The patients were retrospectively
evaluated with regard to vaccination, incubation
period, total and ICU hospitalization duration,
acquired nosocomial infections, noninfectious
conditions, and the mortality rate. Data were obtained
from registered files and from nurses’ clinical
observations. The causes of mortality were stated in
122

the written documents obtained during patient
follow-up as well as in the death records.
Microbiologic methods
Microorganism isolation in the collected culture
samples was conducted in the central laboratory of
our hospital’s microbiology department using the
VITEK 2 automated identification system.
Statistical Analysis
The findings were registered in previously
prepared forms and were statistically analyzed using
SPSS v.11.5.
Results
Mean age of the 15 patients (9 male, 6 female) was
60 ± 13 years. None had been vaccinated in the
previous 10 years. Seven patients had a history of
posttraumatic vaccination, while 1 had a history of
tetanus immunoglobulin administration. Mean
incubation period was 6.5 days (range: 1-15 days).
There was a history of head trauma in 2 patients, foot
trauma in 7 patients, and hand trauma in 5 patients,
whereas no focus could be identified in 1 patient.
During treatment 6 patients (40%) had fever and the
median baseline of creatine phosphokinase (CPK)
was 1358 mg dL−1 (range: 315-5195 mg dL−1). Nine
patients presented to the emergency department with
complaints of generalized contractions. The patients’
characteristics are shown in Table 1.
Patient 4 had diabetes and patient 11 had
hypertension. Urethral and central venous
catheterization was performed in all patients.
Tracheostomy was performed in 12 patients and,
apart from 1 death at admission, all patients required
mechanical ventilation. Median duration in the ICU
was 8 days (range: 1-70 days), whereas the median
hospitalization period was 13 days (range: 1-77 days).
The median hospitalization period among the
patients that died was 7 days (range: 1-59 days), versus
42 days (range: 42-77 days) among the survivors. At
least 1 infectious attack occurred in each patient that
survived. Five patients died due to a clinical entity of
advanced-stage tetanus: 2 due to sepsis, 1 due to
myocardial infarction, 1 due to acute kidney failure,
and 1 due to complications of pancreatitis and acute
kidney failure. The mortality rate was 66% (10 of the
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15 patients died). It was reported that deaths due to
infectious causes occurred during later stages,
whereas deaths due to advanced stage tetanus
occurred most frequently during the first days of
hospitalization. The duration of hospitalization
according to cause of death is shown in Table 2.

Discussion and conclusion
Tetanus was first described 3000 years ago in
Egypt. The World Health Organization (WHO)
reported 18,833 cases of tetanus in 2000, adding that
the figure could actually be higher (11). This is due to
the existence of many high-risk countries that do not
report any cases to the WHO. Tetanus-related deaths
are mostly reported from Africa (80%) and Southeast
Asia (4). The survival rate from neonatal tetanus is
9%. Incidence of the disease has declined over the last
20 years due to primary vaccination programs. In
many countries children born after the vaccination

In all, 16 nosocomial infection attacks were
recorded in 7 patients; the most frequent type was
ventilator-associated pneumonia, followed by primary
bloodstream infection and urinary infection.
Documented nosocomial infections and the
corresponding microorganisms are shown in Table 3.

Table 2. Causes of death and hospitalization duration.
Patient
no.
2
4
5
6
8
9
10
13
14
15

Cause of death

Duration of
hospitalization (days)

Sepsis
Advanced stage of tetanus
Advanced stage of tetanus
Myocardial infarction
Advanced stage of tetanus
Pancreatitis + acute kidney failure
Advanced stage of tetanus
Sepsis
Acute renal failure
Advanced stage of tetanus

42
4
4
5
13
4
1
59
10
9

Table 3. Types of nosocomial infection and the corresponding microorganisms.
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Nosocomial infections

Agents

n

Total

Ventilator-associated pneumonia

A. baumannii
P. aeruginosa
Clinical diagnosis

3
2
2

7

Primary bloodstream infection

P. aeruginosa
E. coli
S. aureus

2
1
1

4

Urinary infection

Candida species
P. aeruginosa
K. pneumonia

2
1
1

4

Soft tissue infection

S. aureus

1

1

Total

-

-

16
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program are at risk and need additional vaccination.
Elderly individuals also represent a risk group, even
in countries such as Turkey, which has an organized
primary immunization program. The reason for this,
apart from incomplete primary vaccinations, is that
the level of protective antibodies decreases over time
(9). A total of 53 adult tetanus patients were followedup in our hospital between 1994 and 2000, whereas
during the past 6 years, only 15 patients were followed
up, which demonstrates a progressively dramatic
decrease in the incidence of tetanus (7). It is important
to note that our hospital remains a reference in the
care of such patients. Nevertheless, the mortality rate
was very high and was generally caused by
nosocomial infections after a prolonged hospital stay.
Advanced age is regarded as an important risk
factor for adult tetanus cases in Turkey. Almost all of
our patients were older than 50 years of age, and none
reported a vaccination history prior to the trauma.
The general factors for high mortality are short
incubation period, severe fever, advanced clinical
entity, and poor prognosis at presentation. These
patients are also exposed to infections in the ICU due
to its specific requirements—mechanical ventilation,
tracheostomy, and catheterization—and prolonged
hospital stay. These conditions increase morbidity,
prolong the duration of hospitalization, and increase
mortality. Apart from nosocomial infections, tetanus
patients are also prone to bedsores, tracheal
obstruction, and gastrointestinal hemorrhage (1,11).
Mortality rates have been reported to be very high in
patients in the advanced stages of the disease and with
acquired nosocomial infections (5). Early intubation
and mechanical ventilation markedly reduce the
mortality rate. It is also known that prevention of
long-term complications, such as nosocomial
pneumonia and deep venous thrombosis, has a
positive effect on the prognosis (4). Another
important finding of the present study was that the
death of 2 patients in the late stage (42nd and 59th day)
was due to sepsis. It has been reported that infection
and other complications in patients with a severe
course of tetanus prolong the duration of
hospitalization (8). As such, it can be suggested that
mortality during the early stage of the disease is due to
the primary disease, whereas mortality during the late
stage is due to complications.

Endotracheal intubation may be performed during
the early stage; however, tracheostomy is reported to
be a better option due to slow recovery and the longterm need for mechanical ventilation. Tracheostomy
prevents spasms of the upper respiratory tract, as well
as respiratory complications such as hypoventilation
and asphyxia. This procedure requires the targeted
areas to be frequently cleaned to maintain sterility.
With long-term ventilatory support, the clinical
course of tetanus may last 4-6 weeks. On the other
hand, minor spasms and increased tonicity may last
for months (4). Ventilator-associated pneumonia was
the most frequently encountered nosocomial
infection in the present study. As mechanical
ventilation was performed in all patients, except 1 that
died within the first 24 h of hospitalization, the
prevalence of ventilator-associated pneumonia
increased. Nosocomial pneumonia is the second most
common cause of hospital-acquired infection and its
mortality rate is estimated to be 30%. Its risk factors
are trauma, respiratory system or cardiac disease,
prolonged mechanical ventilation, re-intubation,
tracheotomy, aspiration of gastric contents, and
paralytic drug use (1). Most of these factors are seen
in tetanus. It has been reported that nosocomial
pneumonia is more frequent in patients with tetanus
than in those with meningitis or other neurologic
diseases; however, mortality associated with
nosocomial pneumonia was lower than with other
neurologic diseases (3).
Gram-negative microorganisms form the majority
of agents responsible for nosocomial infections. These
results correlate with our ICU surveillance data. The
most frequently isolated agents of nosocomial
infection were Pseudomonas aeruginosa and
Acinetobacter baumannii; however, more detailed
information regarding these agents’ frequency and
distribution could not be obtained due to the limited
number of patients and infectious attacks.
Mortality in tetanus varies with patient age. In the
United States mortality in adults younger than 30
years may be as low as zero; however, in those aged
over 60 years, who account for 75% of tetanus deaths,
mortality is above 50%. In Portugal between 1986 and
1990 mortality varied between 32% and 59% among
all age groups (12-14). In the present study being
elderly and admitting with progressive disease are
125
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thought to be the reasons for poor prognosis and 66%
mortality.
The incidence of tetanus has greatly declined, as
compared to previous years, and the presence of even
one case of this preventable disease is regarded as
clinically important. This severe infectious entity,

which is closely followed up in the ICU, is susceptible
to nosocomial infections. Patients and physicians are
challenged equally with additional obstacles to
survival. Despite advances in medical treatment, the
poor prognosis of this disease highlights the need for
national preventive health policies.
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